The global neuroprosthetics market is anticipated to grow at a significant CAGR of 12.7% during the forecast period (2022-2028). The key companies such as Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, Demant AS, LivaNova PLC, and others are operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth.
Browse the full report description of “Global Neuroprosthetics Market Size, Share & Trends Analysis Report by Type (Motor Prosthetics, Sensory Prosthetics, Cognitive Prosthetics, and Visual Prosthetics), by Treatment Technique (Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulator (SNS), and Spinal Cord Stimulator (SCS) and by Application (Motor Disorder, Physiological Disorder, and Cognitive Disorder) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/neuroprosthetics-market
Hence owing to the development and manufacturing of innovative solutions the translucent concrete market is augmenting its growth over the forecast period.
• In August 2020, Medtronic plc, the manufacturer received the FDA approval for the InterStim Micro neurostimulator and InterStim SureScan MRI leads for the treatment of patients with bladder and bowel control conditions.
• In August 2020, Cochlear Ltd received US FDA approval for its new Cochlear Osia?2 System, an active osseointegrated steady-state implant (OSI) that comprises innovative sound magnets and magnetic attachments.
• In March 2020, MED-El received the European Medical Device Regulation (MDR) certification. This certification has made MED-El one of the world’s first manufacturers to receive certification for medical devices of the highest risk class (Class III), Class III Implantable Custom-Made Devices, and Class I reusable surgical instruments.
• In March 2020, Cochlear Limited received the approval from US FDA to lower the age of cochlear implantation from 12 months to 9 months for children with bilateral, profound sensorineural hearing loss.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Treatment Technique
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including include Abbott Laboratories, Boston Scientific Corporation, BrainGate, Cochlear Ltd, Cyberonics Inc., Medtronics Inc., Livanova Plc, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Neuroprosthetics Market Report Segment
By Type
• Motor Prosthetics
• Sensory Prosthetics
• Cognitive Prosthetics
• Visual Prosthetics
By Treatment Technique
• Deep Brain Stimulation (DBS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulator (SNS)
• Spinal Cord Stimulator (SCS)
By Treatment Technique
• Motor Disorder
• Physiological Disorder
• Cognitive Disorder
Global Neuroprosthetics Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/neuroprosthetics-market